Cardiac implications in myasthenia gravis

doi:10.12998/wjcc.v12.i26.5863

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (25)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=23

Sep 16, 2024 (publication date) through Jul 20, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Cases. Sep 16, 2024; 12(26): 5863-5867
Published online Sep 16, 2024. doi: 10.12998/wjcc.v12.i26.5863

Cardiac implications in myasthenia gravis

Praveen Reddy Elmati, Gowthami Sai Kogilathota Jagirdhar, Salim Surani

Praveen Reddy Elmati, Department of Anesthesiology, Saint Clair Hospital, Dover, NJ 07801, United States

Gowthami Sai Kogilathota Jagirdhar, Department of Medicine, Saint Michaels Medical Center, Newark, NJ 07107, United States

Salim Surani, Department of Medicine and Pharmacology, Texas A&M University, College Station, TX 77843, United States

Author contributions: Elmati PR designed the overall concept and outline of the manuscript; Elmati PR and Kogilathota Jagirdhar GS performed the research and literature review; Elmati PR, Kogilathota Jagirdhar GS, and Surani S analyzed the studies and wrote the manuscript; All authors have read and approved the final manuscript.

Conflict-of-interest statement: None of the authors have any conflict of interest to disclose.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Salim Surani, FACP, FCCP, MD, MHSc, Adjunct Professor, Department of Medicine and Pharmacology, Texas A&M University, 40 Bizzell Street, College Station, TX 77843, United States. srsurani@hotmail.com

Received: May 5, 2024
Revised: June 3, 2024
Accepted: June 14, 2024
Published online: September 16, 2024
Processing time: 75 Days and 20.3 Hours

Core Tip

Core Tip: Preoperative cardiac screening is crucial for patients with myasthenia gravis (MG), especially those with thymoma, late-onset MG, or antistriational antibodies. Understanding the link between MG and cardiac conditions such as cardiomyopathy, myocarditis, takotsubo cardiomyopathy, autonomic dysfunction, and arrhythmias is essential for perioperative surgical management. Electrocardiography and Troponin T can be important initial screening tests in patients with high risk suspicion. Comprehensive screening protocols are necessary to mitigate cardiac risks and optimize outcomes in MG patients undergoing surgery.